NFKB1 and diabetes mellitus: For instance, naringenin inhibits NFκB activation in dextran sulphate sodium-induced colitis [59], ethanol-induced liver injury [18], streptozotocin-induced diabetes in mice [60] and rats [61], and experimental stroke [23].